Secondary stroke prevention with ximelagatran versus warfarin in patients with atrial fibrillation: pooled analysis of SPORTIF III and V clinical trials
about
Non-Vitamin K Oral Anticoagulants in Stroke Patients: Practical IssuesUpdate on antithrombotic therapy for stroke prevention in atrial fibrillation.Early and comprehensive management of atrial fibrillation: executive summary of the proceedings from the 2nd AFNET-EHRA consensus conference 'research perspectives in AF'.Antiplatelet therapy in secondary stroke prevention--state of the artPrevention of cardioembolic stroke.How does Chronic Atrial Fibrillation Influence Mortality in the Modern Treatment Era?Stroke prevention: managing modifiable risk factors.Bone health and osteoporosis: the role of vitamin K and potential antagonism by anticoagulants.Early and comprehensive management of atrial fibrillation: proceedings from the 2nd AFNET/EHRA consensus conference on atrial fibrillation entitled 'research perspectives in atrial fibrillation'.Medical prevention of stroke and stroke recurrence in patients with TIA and minor stroke.Preventing cardioembolic stroke in atrial fibrillation with dabigatran.New avenues for anticoagulation in atrial fibrillation.Effect of Digoxin Use Among Medicaid Enrollees With Atrial Fibrillation.Personalized Anticoagulation: Optimizing Warfarin Management Using Genetics and Simulated Clinical Trials.Anticoagulation in women with nonvalvular atrial fibrillation: insights from clinical trials.
P2860
Q26750767-C9E6B8AD-4674-4488-A2A5-2A94B51C831DQ33814131-AA05ACE1-B94D-4BB8-A77C-3AA22295E508Q34609020-5724E6DB-4155-4DD3-9AB7-9975E52C6409Q35216412-A1EBE5A6-E4FA-4F9A-9B8C-A7374456400DQ35648111-F1BB214A-13C6-4A93-9939-EE0FC64710A4Q36021753-EFCD3061-4135-43FB-B6B6-EEB5B07B4537Q36418118-54E939B6-9854-46A9-B0D8-FC5A690087C2Q36955949-02754B3B-0272-46F2-8F78-E1FCBD8CD2BFQ37521378-C0A4E123-4A93-48AE-9425-A2003E698E6DQ37532590-074D465C-89F1-4B8D-93F1-AA3E5127E8F5Q37940877-B77B3B54-F876-4C46-9DCC-6347A1173327Q38065063-A30024F2-5E2E-49B9-85F3-FC1CA7C5ED79Q38788581-B8164700-881A-49E1-A546-D248A57F8955Q48536840-64DBD402-DB1F-41FE-92EC-4D4D3F6922BAQ51730417-7D6C806B-EABF-406C-B818-5C13329B03E8
P2860
Secondary stroke prevention with ximelagatran versus warfarin in patients with atrial fibrillation: pooled analysis of SPORTIF III and V clinical trials
description
2007 nî lūn-bûn
@nan
2007 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի մարտին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
Secondary stroke prevention wi ...... RTIF III and V clinical trials
@ast
Secondary stroke prevention wi ...... RTIF III and V clinical trials
@en
Secondary stroke prevention wi ...... RTIF III and V clinical trials
@nl
type
label
Secondary stroke prevention wi ...... RTIF III and V clinical trials
@ast
Secondary stroke prevention wi ...... RTIF III and V clinical trials
@en
Secondary stroke prevention wi ...... RTIF III and V clinical trials
@nl
prefLabel
Secondary stroke prevention wi ...... RTIF III and V clinical trials
@ast
Secondary stroke prevention wi ...... RTIF III and V clinical trials
@en
Secondary stroke prevention wi ...... RTIF III and V clinical trials
@nl
P2093
P3181
P1433
P1476
Secondary stroke prevention wi ...... RTIF III and V clinical trials
@en
P2093
David Newman
Gregory W Albers
Harvey A Feldman
Paul T Akins
Robert G Zoble
Stefan G Spitzer
P304
P3181
P356
10.1161/01.STR.0000258004.64840.0B
P407
P577
2007-03-01T00:00:00Z